DNA mismatch repair is not disrupted in stage 0 colorectal cancer resected using endoscopic submucosal dissection.

CRC DNA MMR ESD

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 21 02 2020
accepted: 15 06 2020
entrez: 13 8 2020
pubmed: 13 8 2020
medline: 13 8 2020
Statut: ppublish

Résumé

The frequency of deficient mismatch repair (dMMR) or microsatellite instability-high colorectal cancer (CRC) is estimated to be ~15% of all patients with CRC; however, the patients reported are limited to surgical cases, and the frequency of patients exhibiting stage 0 disease is not considered, despite the currently increasing use of endoscopic techniques to cure a number of these patients. In the present study, the DNA MMR status for stage 0 patients with CRC treated using endoscopic submucosal dissection or endoscopic mucosal resection was analyzed via immunohistochemical staining of four types of proteins, namely MutL homolog 1 (MLH1), MutS homolog 2 (MSH2), MSH6 and PMS1 homolog 2 MMR system component, in adenocarcinoma specimens. Notably, none of the endoscopically resected specimens exhibited dMMR among the 41 patients diagnosed with stage 0 CRC. Since tumors harboring dMMR progress more rapidly than tumors with chromosomal instability, the present results highlight the importance of tumor resection during very early phases that exist before the promoter region of

Identifiants

pubmed: 32782560
doi: 10.3892/ol.2020.11799
pii: OL-0-0-11799
pmc: PMC7399995
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2435-2441

Informations de copyright

Copyright: © Sugiyama et al.

Références

Cell. 1996 Oct 18;87(2):159-70
pubmed: 8861899
BMJ Open Gastroenterol. 2019 Jul 24;6(1):e000317
pubmed: 31413858
Gastroenterology. 2004 Dec;127(6):1678-84
pubmed: 15578504
J Natl Cancer Inst. 2013 Aug 7;105(15):1151-6
pubmed: 23878352
Cancer Manag Res. 2018 Jul 31;10:2303-2314
pubmed: 30104899
Gastroenterology. 2004 Feb;126(2):394-401
pubmed: 14762775
Nature. 1998 Dec 17;396(6712):643-9
pubmed: 9872311
Gastroenterology. 2008 Oct;135(4):1079-99
pubmed: 18773902
Br J Cancer. 2016 Jun 28;115(1):25-33
pubmed: 27228287
Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):11-27
pubmed: 15000146
Cancer Biol Ther. 2011 Oct 15;12(8):756-64
pubmed: 21814034
Endosc Int Open. 2017 Sep;5(9):E839-E846
pubmed: 28924587
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
pubmed: 10411935
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369
pubmed: 29632055
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Diagn Pathol. 2018 Nov 20;13(1):88
pubmed: 30458818
Oncogene. 2009 Feb 12;28(6):899-909
pubmed: 19060925
Gut. 2009 Feb;58(2):249-60
pubmed: 18635744
World J Gastroenterol. 2015 Jan 28;21(4):1275-83
pubmed: 25632202
Cancer Res. 1997 Mar 1;57(5):808-11
pubmed: 9041175
J Cancer Res Clin Oncol. 2016 Nov;142(11):2357-66
pubmed: 27573386
Am J Surg Pathol. 2006 Dec;30(12):1491-501
pubmed: 17122504
Anticancer Res. 2017 Jan;37(1):239-247
pubmed: 28011498
Cancer Lett. 2004 Dec 8;216(1):55-62
pubmed: 15500949
PLoS One. 2011;6(12):e28117
pubmed: 22164234
Sci Rep. 2013 Oct 22;3:3012
pubmed: 24146025
Gastroenterology. 2010 Jun;138(6):2073-2087.e3
pubmed: 20420947
Mutat Res. 1990 Sep-Nov;236(2-3):253-67
pubmed: 2144613
Gastroenterol Hepatol Bed Bench. 2013 Summer;6(3):120-8
pubmed: 24834258
Oncogene. 2011 Nov 3;30(44):4453-63
pubmed: 21532624
Dig Endosc. 2015 May;27(4):417-434
pubmed: 25652022
N Engl J Med. 2003 Jul 17;349(3):247-57
pubmed: 12867608
Surg Endosc. 2010 Feb;24(2):343-52
pubmed: 19517168
Gastroenterology. 2020 Jan;158(2):291-302
pubmed: 31622622
Dig Dis Sci. 2009 Apr;54(4):906-9
pubmed: 18688718
Dig Endosc. 2017 Apr;29 Suppl 2:58-65
pubmed: 28425662
Int J Cancer. 2019 Sep 15;145(6):1625-1634
pubmed: 31162857
J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8
pubmed: 16174854
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Gastric Cancer. 2019 Jan;22(1):69-76
pubmed: 29859006
Surg Endosc. 2012 Aug;26(8):2220-30
pubmed: 22278105
Carcinogenesis. 2009 Mar;30(3):494-9
pubmed: 19147861

Auteurs

Tomohiro Sugiyama (T)

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Moriya Iwaizumi (M)

Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Masanao Kaneko (M)

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Shinya Tani (S)

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Mihoko Yamade (M)

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Yasushi Hamaya (Y)

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Takahisa Furuta (T)

Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Hiroaki Miyajima (H)

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Satoshi Osawa (S)

Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Satoshi Baba (S)

Department of Diagnostic Pathology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Masato Maekawa (M)

Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Ken Sugimoto (K)

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Classifications MeSH